PIK3CA and breast cancer: In vitro treatment of PIK3CA-mutant breast cancer brain metastases cell lines with GDC-0084 reduced their viability, induced apoptosis, and inhibited the phosphorylation of AKT and p70S6, highlighting its potential as a therapeutic strategy against breast cancer with brain metastases [97].